Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: There will come a point in time (hopefully the near future) where our

dys1:

I agree, however I do not believe we have anything substantial yet in the pipeline as far as projects for PDSG goes, IMO. Just an educated guess based on the state of the funding for projects we have seen so far, which appear to be in the beginning stages. I expect it to accelerate over the next 3-6 months going into 2010 and beyond, with a commensurate filling of our pipeline. The MMP, on the other hand, appears ready to accelerate immediately. I hope this is the case and that we see an increase in both licenses and the revenue reported from them.

Cheers,

DG

Share
New Message
Please login to post a reply